MRC1 and colorectal carcinoma: This study also identified factors that contribute to an elevated risk of developing subsequent metachronous MPC—specifically, male sex, older age at diagnosis of the index CRC, diagnosis with stage I or II CRC, and reduced expression of MMR proteins.